Pamela Cruz. Pen sula 360 Press [P360P]
Following various tests in experimental laboratories in France and the United States, it was shown that plitidepsin, an antiviral drug produced by the Spanish company PharmaMar, could reduce SARS-CoV-2 viral loads by up to 99 percent.
According to a paper published Monday in the journal Science, in vitro and in vivo experiments already conducted on animals with this drug, used as an antitumor, have demonstrated promising antiviral efficacy and toxicity profile.
Thus, the authors of the study have concluded that plitidepsin is